A prospective randomized study to evaluate the the efficacy of percutaneous transhepatica arterial catheterization with antibiotics injection for treating bacterial liver abscess

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-16007921

Enrollment

Unknown

Registered

2016-02-14

Start date

2016-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial liver abscess

Interventions

Control group:intravenous antibiotic therapy

Intervention group:percutaneous transhepatica arterial catheterization with antibiotics injection

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. good compliance; volunteers cooperated to complete the intervention measures; 2. Patient meets the bacterial liver abscess standard of Western medicine; 3. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe heart, lung, liver or kidney disease; 2. Late-stage cancer; 3. acute infectious diseases, drug or parasite-induced acute hepatitis; 4. human immunodeficiency virus (HIV) infection; 5. Patient does not agree to participate, or not with the treatment.

Design outcomes

Primary

Measure	Time frame
Routine blood;liver and kidney function;Prothrombin time (PT);activated partial thromboplastin time (APTT);blood gas analysis;blood culture;procalcitonin(PCT);CRP;ultrasound;Computed Tomography;body temperature;heart rate;length of hospitalization;hospitalization costs;incidence of complications;	—

Countries

China

Contacts

Public ContactYu Fuxiang

yfxbmu@163.com+86 13868407480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026